// App-Quantinova.ai

382 : Systemic therapy in elderly patients with advanced biliary tract cancer: Sub-analysis of ABC-02 and 10 other prospective studies.

Researchers

Presenter

  • Mairead G McNamara

Principal Investigators

  • John A. Bridgewater

  • Andre Lopes

  • Harpreet Wasan

  • David Malka

  • Henrik R Jensen

  • Takuji Okusaka

  • Jennifer J. Knox

  • Anna Dorothea Wagner

  • David Cunningham

  • Jenny Shannon

  • David Goldstein

  • Markus H. Moehler

  • Tanios S. Bekaii-Saab

  • Juan W. Valle

Medical Centers

  • The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom

  • University College London Hospitals/UCL Cancer Institute, London, United Kingdom

  • Cancer Research UK & University College London Cancer Trials Centre, London, United Kingdom

  • Department of Histopathology, Imperial College London, London, United Kingdom

  • Gustave Roussy, Villejuif, France

  • Odense University Hospital, Odense, Denmark

  • Department of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Japan

  • Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Nepean Cancer Care Centre, Kingswood, Australia

  • Prince of Wales Hospital, University of New South Wales, Cancer Survivors Centre, Sydney, Australia

  • Johannes-Gutenberg Universitat Mainz, Mainz, Germany

  • The Ohio State University Comprehensive Cancer Center, Columbus, OH

  • University of Manchester, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom

Locations

  • United Kingdom

  • France

  • Denmark

  • Japan

  • Canada

  • Switzerland

  • Australia

  • Germany

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Advanced biliary tract carcinoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A